REFERENCES
- Lim DA, Tarapore P, Chang E, et al. Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study. J Neurooncol. 2009;93:349–354.
- Dinapoli L, Maschio M, Jandolo B. Quality of life and seizure control in patients with brain tumor-related epilepsy treated with levetiracetam monotherapy: preliminary data of an open-label study. Neurol Sci. 2009;30:353–359.
- Rossetti AO, Jeckelmann S, Novy J, Roth P, Weller M, Stupp R. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Neuro Oncol. 2014;16:584–588.
- Maschio M, Dinapoli L, Sperati F, et al. Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life. J Neurooncol. 2011;104:205–214.
- Wiffen PJ, Derry S, Moore RA, Lunn MP. Levetiracetam for neuropathic pain in adults. Cochrane Database Syst Rev. 2014;(7):CD010943.
- Jungehulsing GJ, Israel H, Safar N, et al. Levetiracetam in patients with central neuropathic post-stroke pain—a randomized, double-blind, placebo-controlled trial. Eur J Neurol. 2013;20:331–337.
- Falah M, Madsen C, Holbech JV, Sindrup SH. A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis. Eur J Pain. 2012;16:860–869.
- Holbech JV, Otto M, Bach FW, Jensen TS, Sindrup SH. The anticonvulsant levetiracetam for the treatment of pain in polyneuropathy: a randomized, placebo-controlled, cross-over trial. Eur J Pain. 2011;15:608–614.
- UCB, Inc. Keppra injection (levetiracetam) [prescribing information]. Smyrna, GA: UCB, Inc.; March 2015.
- Mylan Institutional LLC. Levetiracetam in sodium chloride injection [prescribing information]. Rockford, IL: Mylan Institutional LLC; November 2011.
- Levetiracetam monograph. In: Handbook on Injectable Drugs. Bethesda, MD. American Society of Health-System Pharmacists, Inc. 2013.
- Prohotsky D, Hughes S, Zhao F. Stability of levetiracetam oral solution repackaged in oral plastic syringes. Am J Health Syst Pharm. 2014;71:219–222.
- General Chapter <1191> Stability Considerations in Dispensing Practice. In: United States Pharmacopeia and National Formulary, USP 38/NF 33. Rockville, MD: United States Pharmacopeia Convention, Inc. 2015.
- Ensom M, Decarie D, Rudolph S. Stability of levetiracetam in extemporaneously compounded suspensions. Can J Hosp Pharm. 2011;62:207–211.
- Hannon PR, Flaws JA. The effects of phthalates on the ovary. Front Endocrinol (Lausanne). 2015;6(8):10–19.
- Bhattacharya N, Dufour JM, Vo MN, Okita J, Okita R, Kim KH. Differential effects of phthalates on the testis and the liver. Biol Reprod. 2005;72:745–754.
- General Chapter <797> Pharmaceutical Compounding - Sterile Preparations. In: United States Pharmacopeia and National Formulary, USP 38/NF 33. Rockville, MD: United States Pharmacopeia Convention, Inc. 2015.